ConductScience.org, home

Paper35948242

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).

Seifert H and 3 others. J Glob Antimicrob Resist, 2022. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018). Papers, record 35948242. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35948242

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).
PubMed
Journal
J Glob Antimicrob Resist
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
4.98
iCite
Revised in PubMed
2022-12-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Seifert HHarald
2Blondeau JJoseph
3Lucaßen KKai
4Utt EAEric A

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acinetobacter baumanniiMajor topic
Tigecycline
Amikacin
Colistin
Meropenem
Levofloxacin
Gram-Negative Bacteria
Anti-Bacterial Agents
Phenotype

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
42654736Virulence and Resistance Mechanisms in Multidrug-Resistant Acinetobacter baumannii.Pathogens2026https://conductscience.org/library/papers/42654736PubMed
42010419Genetic characterization of tigecycline and carbapenem resistant Acinetobacter baumannii in a tertiary care hospital of Northern India.BMC Microbiol2026https://conductscience.org/library/papers/42010419PubMed
41852955Colistin-resistance among Acinetobacter baumannii and Pseudomonas aeruginosa from clinical specimens in Africa: a systematic review and meta-analysis.JAC Antimicrob Resist2026https://conductscience.org/library/papers/41852955PubMed
41471861Transfer and Fitness of ISAba52-Mediated tet(X3) Transposon in Acinetobacter spp.Microorganisms2025https://conductscience.org/library/papers/41471861PubMed
41259442Integrative review on Acinetobacter baumannii as a multidrug-resistant pathogen: resistance mechanisms and therapeutic perspectives in the context of nosocomial infections.Rev Soc Bras Med Trop2025https://conductscience.org/library/papers/41259442PubMed
41180612Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii in ICU Environments: Mobile Genetic Elements, Efflux Pumps, and Resistance Mechanism.Infect Drug Resist2025https://conductscience.org/library/papers/41180612PubMed
40851759Eravacycline Treatment for Carbapenem-Resistant Acinetobacter baumannii in Lung Transplant Recipients: A Real-World Retrospective Study.Infect Drug Resist2025https://conductscience.org/library/papers/40851759PubMed
40631987Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40631987PubMed
40572068Genomic Diversity of the tet(X)-Positive Myroides Species.Microorganisms2025https://conductscience.org/library/papers/40572068PubMed
40555211Detection of the Tigecycline Resistance-Mediating tet(Y) Gene in Acinetobacter baumannii Isolates from Intensive Care Unit Patients in Pakistan.Am J Trop Med Hyg2025https://conductscience.org/library/papers/40555211PubMed
40493197Repurposing a drug to punish carbapenem-resistant Acinetobacter baumannii.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40493197PubMed
40284665The Multifaceted Landscape of Healthcare-Associated Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.Microorganisms2025https://conductscience.org/library/papers/40284665PubMed
40234860The causes and outcomes of nosocomial meningitis by pathogens for which new antibiotics are urgently needed.BMC Infect Dis2025https://conductscience.org/library/papers/40234860PubMed
39680587Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.PLoS One2024https://conductscience.org/library/papers/39680587PubMed
39629993OMP38 of Carbapenem-Resistant Acinetobacter Baumannii-Mediated mtDNA Release Activates the cGAS-STING Signaling to Induce Inflammatory Response.Adv Sci (Weinh)2024https://conductscience.org/library/papers/39629993PubMed
39538087AdeABC, AdeFGH, and AdeIJK efflux pumps as key factors in tigecycline resistance of Acinetobacter baumannii: a study from Western Balkan hospitals.Eur J Clin Microbiol Infect Dis2025https://conductscience.org/library/papers/39538087PubMed
39403207Risk factors and predictive model for nosocomial infections by extensively drug-resistant Acinetobacter baumannii.Front Cell Infect Microbiol2024https://conductscience.org/library/papers/39403207PubMed
39336804Co-Occurrence of Two Plasmids Encoding Transferable blaNDM-1 and tet(Y) Genes in Carbapenem-Resistant Acinetobacter bereziniae.Genes (Basel)2024https://conductscience.org/library/papers/39336804PubMed
39335042Complex Infection-Control Measures with Disinfectant Switch Help the Successful Early Control of Carbapenem-Resistant Acinetobacter baumannii Outbreak in Intensive Care Unit.Antibiotics (Basel)2024https://conductscience.org/library/papers/39335042PubMed
39206228
Factors associated with antibiotic resistance and survival analysis of severe pneumonia patients infected with Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa: A retrospective cohort study in Jakarta, Indonesia.
SAGE Open Med2024https://conductscience.org/library/papers/39206228PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35948242

GET https://conductscience.org/api/papers/v1/35948242/cited_by?page=2